Screening for novel antibacterial agents based on the activities of compounds on metabolism of Escherichia coli: A microcalorimetric study

Journal of Hazardous Materials

Volumn 185, Issue 1, 2011, Pages 346-352

  Kong, Weijun ^a,b   Wang, Jiabo ^a   Xing, Xiaoyan ^a,b   Jin, Cheng ^a   Xiao, Xiaohe ^a   Zhao, Yanling ^a   Zhang, Ping ^a   Zang, Qingce ^a,c   Li, Zulun ^b  

^a BEIJING 302 HOSPITAL   (China)

^b CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Antibacterial agent; E. coli; Microcalorimetry; Multiplying bacteria; Non multiplying latent bacteria

Indexed keywords

ANTIBACTERIAL AGENT; E. COLI; MICROCALORIMETRY; MULTIPLYING BACTERIA; NON-MULTIPLYING LATENT BACTERIA;

ACIDS; ESCHERICHIA COLI; METABOLISM;

BACTERIOLOGY;

CHENODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID;

CALORIMETRY; COLIFORM BACTERIUM; DRUG RESISTANCE; FERMENTATION; GROWTH RATE; METABOLISM; REACTION KINETICS;

AEROBIC METABOLISM; ANAEROBIC FERMENTATION; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL METABOLISM; CONTROLLED STUDY; DRUG DETERMINATION; DRUG SCREENING; DRUG STRUCTURE; ESCHERICHIA COLI; HEAT; IC 50; MICROCALORIMETRY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; THERMODYNAMICS;

ALGORITHMS; ANTI-BACTERIAL AGENTS; CALORIMETRY; CHENODEOXYCHOLIC ACID; CULTURE MEDIA; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; SOLVENTS; THERMODYNAMICS; URSODEOXYCHOLIC ACID;

ESCHERICHIA COLI;

EID: 78549263343     PISSN: 03043894     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2010.09.040     Document Type: Article

References (28)

1. Morens D.M., Folkers G.K., Fauci A.S. The challenge of emerging and reemerging infectious diseases. Nature 2004, 430:242-249.
2. Alekshun M.N., Levy S.B. Molecular mechanisms of antibacterial multidrug resistance. Cell 2007, 128:1037-1050.
3. Jones K.E., Patel N.G., Levy M.A., Storeygard A., Balk D., Gittleman J.L., Daszak P. Global trends in emerging infectious diseases. Nature 2008, 451:990-994.
4. Sommer M.O.A., Dantas G., Church G.M. Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 2009, 325:1128-1131.
5. Saravanakumari P., Mani K. Structural characterization of a novel xylolipid biosurfactant from Lactococcus lactis and analysis of antibacterial activity against multi-drug resistant pathogens. Bioresour Technol. 2010, 101:8851-8854.
6. Haydon D.J., Stokes N.R., Ure R., Galbraith G., Bennett J.M., Brown D.R., Baker P.J., Barynin V.V., Rice D.W., Sedelnikova S.E., Heal J.R., Sheridan J.M., Aiwale S.T., Chauhan P.K., Srivastava A., Taneja A., Collins I., Errington J., Czaplewski L.G. An inhibitor of FtsZ with potent and selective anti-staphylococcal activity. Science 2008, 321:1673-1675.
7. Dantas G., Sommer M.O.A., Oluwasegun R.D., Church G.M. Bacteria subsisting on antibiotics. Science 2008, 320:100-103.
8. Zlitni S., Brown E.D. Not as fab as we thought. Nature 2009, 458:39-40.
9. Fischbach M.A., Walsh C.T. Antibiotics for emerging pathogens. Science 2009, 325:1089-1093.
10. Coates A., Hu Y.M., Bax R., Page C. The future challenges facing the development of new antimicrobial compounds. Nat. Rev. Drug. Disc. 2002, 1:895-910.
11. Projan S.J. New (and not so new) antibacterial targets from where and when will the novel compounds come?. Curr. Opin. Pharmacol. 2002, 2:513-522.
12. Pallen M.J., Wren B.W. Bacterial pathogenomics. Nature 2007, 449:835-842.
13. Payne D.J. Desperately seeking new antibiotics. Science 2008, 321:1644-1645.
14. Coates A.R.M., Hu Y.M. Targeting non-multiplying organisms as a way to develop novel antimicrobials. Trends. Pharmacol. Sci. 2008, 29:143-150.
15. Coates A.R.M., Hu Y.M. New strategies for antibacterial drug design: targeting non-multiplying latent bacteria. Compounds. R. D. 2006, 7:133-151.
16. Spoering A.L., Lewis K. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J. Bacteriol. 2001, 183:6746-6751.
17. Costerton J.W., Stewart P.S. Greenberg bacterial biofilms: a common cause of persistent infections. Science 1999, 284:1318-1322.
18. von Ah U., Wirz D., Daniels A.U. Rapid MSSA-MRSA differentiation and MIC determinations by isothermal microcalorimetry. J. Clin. Microbiol. 2008, 46:2083-2087.
19. von Ah U., Wirz D., Daniels A.U. Isothermal microcalorimetry-a new method for MIC determinations: results for 12 antibiotics and reference strains of E. coli and S. aureus. BMC. Microbiol. 2009, 9:106-120.
20. Kong W.J., Wang J.B., Jin C., Zhao Y.L., Dai C.M., Xiao X.H., Li Z.L. Effect of emodin on Candida albicans growth investigated by microcalorimetry combined with chemometric analysis. Appl. Microbiol. Biotechnol. 2009, 83:1183-1190.
21. 5 growth investigated by microcalorimetry. J. Hazard. Mater. 2009, 168:609-613.
22. Braissant O., Wirz D., Göpfert B., Daniels A.U. "The heat is on": rapid microcalorimetric detection of mycobacteria in culture. Tuberculosis 2010, 90:57-59.
23. Braissant O., Wirz D., Göpfert B., Daniels A.U. Use of isothermal microcalorimetry to monitor microbial activities. FEMS Microbiol. Lett. 2009, 303:1-8.
24. Xie C.L., Tang H.K., Song Z.H., Qu S.S. Microcalorimetric study of bacterial growth. Thermochim. Acta 1988, 123:33-41.
25. O'Neill M.A.A., Vine G.J., Beezer A.E., Bishop A.H., Hadgraft J., Labetoulle C., Walker M., Bowler P.G. Antimicrobial properties of silver-containing wound dressings: a microcalorimetric study. Int. J. Pharm. 2003, 263:61-68.
26. Hu Y.M., Coates A.R.M. Increased levels of sigJ mRNA in late stationary phase cultures of Mycobacterium tuberculosis detected by DNA array hybridisation. FEMS Microbiol. Lett. 2001, 202:59-65.
27. Uyttendaele M., Taverniers I., Debevere J. Effect of stress induced by suboptimal growth factors on survival of Escherichia coli O157:H7. Int. J. Food. Microbiol. 2001, 66:31-37.
28. Vigil K.J., Adachi J.A., Aboufaycal H., Hachem R.Y., Reitzel R.A., Jiang Y., Tarrand J.J., Chemaly R.F., Bodey G.P., Rolston K.V., Raad I. Multidrug-resistant Escherichia coli bacteremia in cancer patients. Am. J. Infect. Control 2009, 37:741-745.